tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AGIO Stock Latest News

JPMorgan biotech analysts hold an analyst/industry conference call
The FlyJPMorgan biotech analysts hold an analyst/industry conference call
16d ago
AGIO
BLUE
Agios Pharmaceuticals presents results from Phase 3 ENERGIZE study of mitapivat
PremiumThe Fly
Agios Pharmaceuticals presents results from Phase 3 ENERGIZE study of mitapivat
17d ago
AGIO
Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
PremiumPress Releases
Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress
18d ago
AGIO
Intellia Therapeutics appoints Brian Goff to board of directors
PremiumThe Fly
Intellia Therapeutics appoints Brian Goff to board of directors
19d ago
AGIO
NTLA
Agios Pharmaceuticals reinstated with a Neutral at JPMorgan
PremiumThe Fly
Agios Pharmaceuticals reinstated with a Neutral at JPMorgan
20d ago
AGIO
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET
PremiumPress ReleasesUpdated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET
27d ago
AGIO
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
PremiumThe Fly
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
30d ago
AGIO
RPRX
Agios reports Phase 3 ENERGIZE-T study of mitapivat met primary endpoint
PremiumThe Fly
Agios reports Phase 3 ENERGIZE-T study of mitapivat met primary endpoint
30d ago
AGIO
Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia
PremiumPress Releases
Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia
30d ago
AGIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AGIO
ARCT
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
PremiumPress Releases
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
1M ago
AGIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AGIO
ARCT
Agios investors paying nothing for Pyrukynd, says Cantor Fitzgerald
PremiumThe FlyAgios investors paying nothing for Pyrukynd, says Cantor Fitzgerald
1M ago
AGIO
Royalty Pharma, Agios enter into vorasidenib royalty agreement
PremiumThe Fly
Royalty Pharma, Agios enter into vorasidenib royalty agreement
1M ago
AGIO
RPRX
Agios Pharmaceuticals announces $905M purchase agreement for vorasidenib royalty
PremiumThe Fly
Agios Pharmaceuticals announces $905M purchase agreement for vorasidenib royalty
1M ago
AGIO
RPRX
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
PremiumPress Releases
Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress
2M ago
AGIO
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
PremiumPress Releases
Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
2M ago
AGIO
Agios Pharmaceuticals expects cash to fund expenditures at least into 2026
PremiumThe Fly
Agios Pharmaceuticals expects cash to fund expenditures at least into 2026
2M ago
AGIO
Agios Pharmaceuticals announces anticipated 2024 milestones
PremiumThe Fly
Agios Pharmaceuticals announces anticipated 2024 milestones
2M ago
AGIO
Agios Pharmaceuticals reports Q1 EPS ($1.45), consensus ($1.65)
PremiumThe FlyAgios Pharmaceuticals reports Q1 EPS ($1.45), consensus ($1.65)
2M ago
AGIO
Agios Reports Business Highlights and First Quarter 2024 Financial Results
PremiumPress Releases
Agios Reports Business Highlights and First Quarter 2024 Financial Results
2M ago
AGIO
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
PremiumPress Releases
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
3M ago
AGIO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >